AbbVie EBIT 2012-2026 | ABBV

AbbVie EBIT for the quarter ending March 31, 2026 was $3.990B, a 6.88% increase year-over-year.

  • AbbVie 2025 EBIT was 15.075B, a 64.99% increase from 2024.
  • AbbVie 2024 EBIT was 9.137B, a 28.38% decline from 2023.
  • AbbVie 2023 EBIT was 12.757B, a 29.59% decline from 2022.

EBIT can be defined as earnings before interest and taxes.

AbbVie EBIT 2012-2026 | ABBV

  • AbbVie 2025 EBIT was 15.075B, a 64.99% increase from 2024.
  • AbbVie 2024 EBIT was 9.137B, a 28.38% decline from 2023.
  • AbbVie 2023 EBIT was 12.757B, a 29.59% decline from 2022.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B